Finerenone + SGLT2 inhibitors

Intervention

1 paper1 finding

  • 1 lab in 2 countries
  • Humans1

Outcomes

1

Urinary albumin-to-creatinine ratio

downin humans1

1 study
  1. Finerenone + SGLT2 inhibitors decrease urinary albumin-to-creatinine ratio in humans (-50.6% (95% CI 28.3-65.9%)).

    Humansin adults with T2DM-related CKD6 months

    Finerenone-Based Dual Versus Triple Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus Associated Chronic Kidney Disease: A Retrospective Cohort Study

    Clinical therapeutics8 Sep 2026

More on Urinary albumin-to-creatinine ratio

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01 in 12 months